vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · IEX Real-Time Price · USD
21.20
+0.11 (0.52%)
At close: Jul 26, 2024, 4:00 PM
13.00
-8.20 (-38.68%)
After-hours: Jul 26, 2024, 6:47 PM EDT

vTv Therapeutics Revenue

vTv Therapeutics had revenue of $1.00M in the quarter ending March 31, 2024. This brings the company's revenue in the last twelve months to $1.00M, up 5,455.56% year-over-year.

Revenue (ttm)
$1.00M
Revenue Growth
+5,455.56%
P/S Ratio
51.58
Revenue / Employee
$62,500
Employees
16
Market Cap
51.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20222.02M-1.99M-49.61%
Dec 31, 20214.01M-2.41M-37.56%
Dec 31, 20206.41M3.65M132.05%
Dec 31, 20192.76M-9.67M-77.77%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 86.62M
Neuronetics 73.23M
HOOKIPA Pharma 53.55M
Allurion Technologies 48.78M
Adlai Nortye 5.00M
Barinthus Biotherapeutics 334.00K
Revenue Rankings